<DOC>
	<DOCNO>NCT02286804</DOCNO>
	<brief_summary>Up 30 enrolled subject treat . Enrolled subject receive Ultherapy® treatment along length spider vein . Follow-up visit occur 30 60 day post-treatment . Study image obtain pre-treatment , immediately post-treatment , follow-up visit .</brief_summary>
	<brief_title>Ultherapy Treatment Spider Veins Legs</brief_title>
	<detailed_description>This study prospective , single center , clinical trial conduct one clinical site . Enrolled subject receive three Ultherapy® treatment single depth , 14 day apart , use 10-1.5mm transducer . Treatment provide along length spider vein four vein treat per subject Maximum length vein treat 2cm .</detailed_description>
	<mesh_term>Telangiectasis</mesh_term>
	<criteria>Female , age 18 year old . Subject good health . Fitzpatrick Skin Types IIII . Understands accepts obligation undergo elective procedure , i.e. , laser IPL , area treat followup period . Has 4 separate spider vein measure 2 cm length depth approximately 1.0mm . Has low extremity spider vein ≤1.0mm diameter , linear branching , red , pink , blue and/or purple color , assess Investigator . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . Subjects childbearing potential must negative urine pregnancy test result must lactate Screening Visit willing able use acceptable method birth control ( e.g . barrier method use spermicidal agent , hormonal method , IUD , surgical sterilization , abstinence ) study . Women consider childbearing potential one follow condition document medical history : 1 . Postmenopausal least 12 month prior study ; 2 . Without uterus and/or ovary ; 3 . Bilateral tubal ligation least six month prior study enrollment . Absence physical psychological condition unacceptable investigator . Willingness refrain use aspirin , Ibuprofen , Naproxen NSAID prior study treatment chronic use entire posttreatment study period . Washout period , chronic user , 4 week prior first treatment . Washout period limit acute NSAID use , i.e. , maximum 23 dos , require 2 week prior study treatment visit . Willingness ability provide write consent studyrequired photography adherence photography procedure ( i.e. , removal jewelry makeup ) . Willingness ability provide write informed consent HIPAA authorization prior performance studyrelated procedure Presence active systemic local skin disease may affect wound healing . Presence significant varicosity perforator vein area ( ) treat . Presence large torturous varicose vein area ( ) treat . Significant scarring area ( ) treat . Open wound lesion area ( ) treat . Active implant metallic implant treatment area . Presence underlying metal hardware attach bone previous surgery . Inability understand protocol give inform consent . BMI equal great 30 . History chronic drug alcohol abuse . History diabetes . History keloid scarring , hypertrophic scar abnormal wound healing . History immunosuppression/immune deficiency disorder currently use immunosuppressive medication . History thromboembolic disease , deep vein thrombosis ( DVT ) . History autoimmune disease . Concurrent therapy , investigator 's opinion , would interfere evaluation safety efficacy study device . Subjects anticipate need surgery overnight hospitalization study . Subjects , investigator 's opinion , history poor cooperation , noncompliance medical treatment , unreliability . Concurrent enrollment study involve use investigational device drug . Current smoker history smoking last five year . History use follow prescription medication : 1 . Accutane systemic retinoids within past six month ; 2 . Antiplatelet agents/Anticoagulants ( Coumadin , Heparin , Plavix ) ; 3 . Chronic use nonsteroidal antiinflammatories ( naproxen , ibuprofen , etc . ) within past 4 week ; 4 . Psychiatric drug investigator opinion would impair subject understand protocol requirement understand signing informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>